Insider Filing: TNON Chief Commercial Officer Reports Direct and Indirect Holdings

Rhea-AI Filing Summary

Nathaniel A. Grawey, Chief Commercial Officer of Tenon Medical (TNON), reported beneficial ownership on a Form 3. He directly holds 138,114 shares of common stock, which are stated to be subject to a vesting schedule and non-transferable, and has an indirect interest in 175,383 shares through SiVantage, Inc. SiVantage owns 710,300 shares and Grawey holds 24.69% of that company.

Insights

Corporate Governance Expert

TL;DR: Routine disclosure of insider holdings showing direct and indirect ownership with a vesting condition on direct shares.

The Form 3 documents Nathaniel Grawey's position as Chief Commercial Officer and quantifies his economic exposure to Tenon Medical: 138,114 directly held common shares (subject to vesting and non-transferability) plus an indirect interest of 175,383 shares via SiVantage, where he owns 24.69%. This is a standard, non-eventful governance disclosure that enhances transparency about insider alignment.

Securities Analyst

TL;DR: Insider disclosed a total beneficial interest of 313,497 common shares, split between direct and indirect holdings.

The filing shows explicit share counts and the structure of indirect ownership: SiVantage holds 710,300 shares and Grawey's stake in SiVantage translates to 175,383 TNON shares. The direct holdings (138,114) being subject to vesting and non-transferable may affect near-term liquidity of those shares. The disclosure is informational and does not indicate a material corporate development.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Grawey Nathaniel A.

(Last) (First) (Middle)

104 COOPER COURT

(Street)

LOS GATOS CA 95032

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/01/2025

3. Issuer Name and Ticker or Trading Symbol
Tenon Medical, Inc. [ TNON ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock(1)	138,114	D
Common Stock(2)	175,383	I	By SiVantage, Inc.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Subject to a vesting schedule and non-transferable.

2. Reflects the reporting person's indirect interest in 710, 300 shares owned by SiVantage, Inc., a corporation in which the reporting person has a 24.69% equity interest.

	/s/ Nathaniel Grawey	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What shares did Nathaniel Grawey report on the Form 3 for Tenon Medical (TNON)?

He reported 138,114 direct common shares and an indirect interest in 175,383 common shares through SiVantage, Inc.

What is the nature of the direct shares reported by Nathaniel Grawey?

The 138,114 directly held shares are stated to be subject to a vesting schedule and non-transferable.

How does SiVantage, Inc. factor into Grawey's indirect ownership?

SiVantage owns 710,300 TNON shares and Grawey holds 24.69% of SiVantage, which corresponds to an indirect interest of 175,383 shares.

What total number of TNON shares does Grawey have a beneficial interest in according to the filing?

The filing implies a total beneficial interest of 313,497 shares (138,114 direct + 175,383 indirect).

What role does Nathaniel Grawey have at Tenon Medical as stated on the form?

He is identified as an Officer with the title Chief Commercial Officer.